.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Revert Cannabis New York is stocked at 215 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and Schenectady. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Revert Cannabis New York concentrated 61.06% of sales in Flower, where year-over-year sales fell 49.75% while month-over-month inched up 1.91%, and the brand held rank 13 in Flower within New York. Offsetting that contraction, Pre-Roll grew 23.09% YoY and 14.39% MoM to 24.47% share, and Vapor Pens expanded 143.75% YoY and 3.07% MoM to 11.64% share; meanwhile, Edible slipped 15.50% MoM to 2.83% share with no YoY read. With average price down 35.47% YoY to $21.19 alongside a Flower-heavy mix and a rank at 13, the pattern implies a pivot toward value-driven formats (Pre-Roll, Vapor Pens) that partially cushions Flower attrition without yet changing the lead category.
The mix shift—Pre-Roll +14.39% MoM and Vapor Pens +3.07% MoM against Flower’s modest +1.91% MoM and deep −49.75% YoY—implies Revert Cannabis New York is trading consumers into lower-ticket, higher-velocity segments as the average price fell 35.47% YoY. Holding 61.06% in Flower while rank sits at 13 in New York and Pre-Roll advances to 24.47% share indicates near-term positioning as a price-competitive hybrid: protecting Flower scale while leaning on Pre-Roll and Vapor Pens growth to stabilize overall sales despite a −31.59% brand-level YoY decline.
Competitive Landscape
Revert Cannabis New York sits at rank #13 in NY Flower in October 2026, down 10 spots from its peak of #3 in November 2025 but up 10 ranks year over year from #23, while slipping 3 positions from #10 in July 2026; meanwhile, Leal moved from #2 to #1 and RYTHM advanced from #7 to #3 with 44.2% YoY sales growth, indicating competitors are consolidating upper-tier positions as Revert Cannabis New York drifts from the top 10. This mix of a 10-rank YoY climb alongside a 3-rank slide in the last quarter, contrasted with Find. rising from #5 to #2 on 36.2% YoY sales growth and Grassroots jumping from #14 to #5 on 112.3% YoY sales growth, implies Revert Cannabis New York’s trajectory is stabilizing mid-pack rather than re-accelerating toward its November 2025 peak.
Notable Products
Revert Cannabis New York leans on a broad lineup priced below peers, with average prices 13.1% under similar products in October 2026. That discount spans headliners like Blue Dream (14g), while the top 10 items account for 30.4% of sales, so revenue is spread across many SKUs rather than a couple of hits.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
